CDKN2A and liver dysplastic nodule: By showing that metformin reduces P16INK4a expression, shifts macrophage polarization toward an anti-inflammatory phenotype, and downregulates both FOXO1 and FABP4, this study provides a mechanistic rationale for incorporating metformin into anti-aging strategies in DN.